This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Epipen Jr. (2017-03-31)
- Starting date:
- March 31, 2017
- Posting date:
- April 4, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-62924
Affected Products
A. Epipen Jr. (.15 mg)
B. Epipen (.3 mg)
Reason
Malfunction of the affected lots' auto-injector that may impact dispensing of the product
Depth of distribution
Retailers
Affected products
A. Epipen Jr. (.15 mg)
DIN, NPN, DIN-HIM
DIN 00578657
Dosage form
A. Sterile liquid for injection
Strength
A. 0.15 mg epinephrine
Lot or serial number
A. 5GR765
Companies
- Recalling Firm
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
- Marketing Authorization Holder
-
Mylan Specialty LP
781 Chestnut Ridge Road
Morgantown
26504-4310
West Virginia
UNITED STATES
B. Epipen Jr. (.3 mg)
DIN, NPN, DIN-HIM
B. DIN 00509558
Dosage form
B. sterile liquid for injection
Strength
B. 0.3 mg epinephrine
Lot or serial number
B. 5GU763
Companies
- Recalling Firm
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
- Marketing Authorization Holder
-
Mylan Specialty LP
781 Chestnut Ridge Road
Morgantown
26504-4310
West Virginia
UNITED STATES